Abstract:Abstract-Chronic hypoxic exposure induces changes in the structure of pulmonary arteries, as well as in the biochemical and functional phenotypes of each of the vascular cell types, from the hilum of the lung to the most peripheral vessels in the alveolar wall. The magnitude and the specific profile of the changes depend on the species, sex, and the developmental stage at which the exposure to hypoxia occurred. Further, hypoxia-induced changes are site specific, such that the remodeling process in the large ve… Show more
“…Changes in VEGF expression together with hypoxia has been shown to be important in the onset of vascular remodelling [123], and may have an important role in the pathophysiology of COPD. Basic FGF and VEGF are key mediators in angiogenesis processes in the airways and promote proliferation of endothelial cells in vitro [124] and may therefore have a central role in angiogenesis in COPD.…”
Section: Vascular Changes and Growth Factors In Copdmentioning
In chronic lung disorders such as in asthma and chronic obstructive pulmonary disease (COPD) there is increased bronchial angiogenesis and remodelling of pulmonary vessels culminating to altered bronchial and pulmonary circulation. The involvement of residential cells such as endothelial cells, smooth muscle cells and pulmonary fibroblasts, all appear to have a crucial role in the progression of vascular inflammation and remodelling. The regulatory abnormalities, growth factors and mediators implicated in the pulmonary vascular changes of asthma and COPD subjects and potential therapeutic targets have been described in this review.
“…Changes in VEGF expression together with hypoxia has been shown to be important in the onset of vascular remodelling [123], and may have an important role in the pathophysiology of COPD. Basic FGF and VEGF are key mediators in angiogenesis processes in the airways and promote proliferation of endothelial cells in vitro [124] and may therefore have a central role in angiogenesis in COPD.…”
Section: Vascular Changes and Growth Factors In Copdmentioning
In chronic lung disorders such as in asthma and chronic obstructive pulmonary disease (COPD) there is increased bronchial angiogenesis and remodelling of pulmonary vessels culminating to altered bronchial and pulmonary circulation. The involvement of residential cells such as endothelial cells, smooth muscle cells and pulmonary fibroblasts, all appear to have a crucial role in the progression of vascular inflammation and remodelling. The regulatory abnormalities, growth factors and mediators implicated in the pulmonary vascular changes of asthma and COPD subjects and potential therapeutic targets have been described in this review.
“…In the current study, we noted a significant increase in the percentage of proliferating α-SMA-positive cells in the pulmonary vascular medial wall on exposure to hyperoxia. These α-SMA-positive cells may originate from the proliferation of resident vascular smooth muscle cells, adventitial fibroblasts, recruitment of vascular progenitors cells, and transition of endothelial cells into a mesenchymal phenotype (32)(33)(34)(35). Inhibition of LRP5/6 during hyperoxia resulted in a decrease in the percentage of proliferating α-SMA cells in the pulmonary vascular medial wall.…”
Section: Mesd and Hyperoxic Neonatal Lung Injurymentioning
Background: Hyperoxia-induced neonatal lung injury is associated with activation of Wnt/ÎČ-catenin signaling. Lowdensity lipoprotein receptor-related proteins 5 and 6 (LRP5/6) are Wnt coreceptors that bind to Wnt ligands and mediate canonical Wnt/ÎČ-catenin signaling. We hypothesized that inhibition of LRP5/6 by their universal inhibitor, Mesd, would attenuate hyperoxia-induced lung injury. Methods: Newborn rat pups were randomly exposed to normoxia or hyperoxia at 90% FiO 2 and injected intraperitoneally with placebo or Mesd every other day for 14 d. On day 15, phosphorylation of LRP5/6 (pLRP5/6), expression of Wnt/ ÎČ-catenin target genes, cyclin D1 and Wnt-induced signaling protein-1 (WISP-1), right-ventricular systolic pressure (RVSP), right-ventricular hypertrophy (RVH), pulmonary vascular remodeling, alveolarization, and vascularization were measured. results: Hyperoxia exposure markedly induced pLRP5/6, cyclin D1, and WISP-1 expression in the lungs of placebo animals, but they were significantly attenuated by the administration of Mesd. Mesd also significantly attenuated hyperoxiainduced pulmonary hypertension (PH) and pulmonary vascular remodeling. However, there was no effect on alveolarization or vascularization after Mesd administration. conclusion: This study demonstrates that LRP5/6 mediates pulmonary vascular remodeling and PH in hyperoxia-induced neonatal lung injury, thereby suggesting a potential therapeutic target to alleviate PH in neonates with severe bronchopulmonary dysplasia.
“…98 Given that extension of smooth muscle into the distal pulmonary vasculature is the hallmark of hypoxia-induced remodeling, substantial focus has been placed on the growth and survival responses of PASMCs to hypoxia. Although the proliferative response is still not completely understood, it is clearly complex, involving a multiplicity of pathways.…”
Section: Role Of Nhe1 In Acute Hypoxic Pulmonary Vasoconstriction (Hpv)mentioning
Intracellular pH (pH i ) homeostasis is key to the functioning of vascular smooth muscle cells, including pulmonary artery smooth muscle cells (PASMCs). Sodium-hydrogen exchange (NHE) is an important contributor to pH i control in PASMCs. In this review, we examine the role of NHE in PASMC function, in both physiologic and pathologic conditions. In particular, we focus on the contribution of NHE to the PASMC response to hypoxia, considering both acute hypoxic pulmonary vasoconstriction and the development of pulmonary vascular remodeling and pulmonary hypertension in response to chronic hypoxia. Hypoxic pulmonary hypertension remains a disease with limited therapeutic options. Thus, this review explores past efforts at disrupting NHE signaling and discusses the therapeutic potential that such efforts may have in the field of pulmonary hypertension.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citationsâcitations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.